Industry News

• OncoGenex announces plans for initiation of Cedar(TM) clinical trial Evaluating OGX-427  OncoGenex announced plans for the initiation of the Cedar™ clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
  May 23, 2013  
• UBC engineer helps pioneer flat spray-on optical lens  A University of British Columbia engineer and a team of U.S. researchers have made a breakthrough utilizing spray-on technology that could revolutionize the way optical lenses are made and used. Their work – the development of a flat lens – is published in the journal Nature.
  May 23, 2013  
• BIOTRONIK announces completion of enrollment in IMPACT study to investigate stroke risk  BIOTRONIK announced that enrollment has been completed for the highly anticipated IMPACT study. The study aims to investigate whether use of BIOTRONIK Home Monitoring® in conjunction with anticoagulation can reduce the risks of stroke, systemic embolism and major bleeding in cardiac device patients.
  May 23, 2013  
• Key vildagliptin data show HbA1c treatment goals can be reached in elderly type 2 diabetes  Results of the INTERVAL study were published in The Lancet and for the first time demonstrated feasibility of setting and achieving individualized treatment targets in elderly patients with type 2 diabetes.
  May 23, 2013  
• One year data demonstrates safe, rapid and sustained blood pressure reduction  St. Jude Medical announced their EnligHTN™ Multi-Electrode Renal Denervation System provides a safe, rapid and sustained reduction in blood pressure measurements after one year. The longer-term safety profile for renal denervation was supported by showing no significant changes in kidney function.
  May 23, 2013  
• Medtronic CoreValve system gains first approval for transcatheter valve-in-valve procedure  Medtronic announced it has received CE Mark for valve-in-valve procedures using the CoreValve® and CoreValve® Evolut(TM) transcatheter aortic valve implantation systems in degenerated bioprosthetic surgical aortic valves. This is the first ever regulatory approval for VIV procedures.
  May 23, 2013  
• Medtronic's In.Pact Falcon drug-eluting balloon yields positive outcomes  One-year data from an Italian multicenter randomized controlled trial of the IN.PACT Falcon drug-eluting balloon from Medtronic demonstrate positive and durable clinical results with the novel angioplasty device in treatment of stenotic de novo lesions in small coronary arteries.
  May 23, 2013  
• Alkermes reports financial results for fiscal year 2013  Alkermes reported GAAP net income increased to $25.0 million for fiscal 2013 versus a net loss of $113.7 million for the prior fiscal year. Total revenues increased 48% to $575.5 million for the 2013 fiscal year versus revenues of $390.0 million for the 2012 fiscal year.
  May 23, 2013  
• Apricus Biosciences prices $17.1 million public offering of common stock and warrants  Apricus announced it has priced an underwritten public offering of an aggregate of 6,000,000 shares of common stock at a price to the public of $2.85 per share, and warrants to purchase up to an aggregate of 3,000,000 shares of common stock for gross offering proceeds of $17,100,000.
  May 23, 2013  
• Chembio awarded $750,000 Cooperative Research Agreement  Chembio announced it has been awarded a cooperative research agreement for up to $750,000 for an eight month development project. The project is to develop rapid POC diagnostic tests for five infectious diseases associated with febrile illness and to multiplex them into one assay.
  May 23, 2013  

(previous 10 articles)    (next 10 articles)